Literature DB >> 11861041

Estrogenic hormone action in the heart: regulatory network and function.

Fawzi A Babiker1, Leon J De Windt, Martin van Eickels, Christian Grohe, Rainer Meyer, Pieter A Doevendans.   

Abstract

Cardiovascular diseases are the leading cause of death in the industrialised countries and display significant gender-based differences. Estrogen plays an important role in the pathogenesis of heart disease and is able to modulate the progression of cardiovascular disease. The focus on the beneficial influence of estrogen is gradually shifting from the vascular system to the myocardium. The presence of functional estrogen receptors in the myocardium has been demonstrated. Estrogen is important for cardiovascular baseline physiology and modulates the myocardial response under pathological conditions. Here we summarise the current knowledge of the regulatory network of estrogenic action in the myocardium and its effects on cardiovascular function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861041     DOI: 10.1016/s0008-6363(01)00526-0

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  38 in total

1.  Rapid estrogen receptor-mediated mechanisms determine the sexually dimorphic sensitivity of ventricular myocytes to 17β-estradiol and the environmental endocrine disruptor bisphenol A.

Authors:  Scott M Belcher; Yamei Chen; Sujuan Yan; Hong-Sheng Wang
Journal:  Endocrinology       Date:  2011-12-13       Impact factor: 4.736

2.  The difference between ballistocardiography and stem cells.

Authors:  P A Doevendans; E van Belle
Journal:  Neth Heart J       Date:  2008-09       Impact factor: 2.380

Review 3.  Heart failure in women.

Authors:  Denise D Barnard
Journal:  Curr Cardiol Rep       Date:  2005-05       Impact factor: 2.931

Review 4.  Steroid hormone receptors as prognostic markers in breast cancer.

Authors:  Maggie C Louie; Mary B Sevigny
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

5.  Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice.

Authors:  S Jeson Sangaralingham; M Yat Tse; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2007-08-23       Impact factor: 3.396

6.  The role of gender differences in beta-adrenergic receptor responsiveness of diabetic rat heart.

Authors:  Ayca Bilginoglu; Figen Amber Cicek; Mehmet Ugur; Hakan Gurdal; Belma Turan
Journal:  Mol Cell Biochem       Date:  2007-06-19       Impact factor: 3.396

7.  Low-dose bisphenol A and estrogen increase ventricular arrhythmias following ischemia-reperfusion in female rat hearts.

Authors:  Sujuan Yan; Weizhong Song; Yamei Chen; Kui Hong; Jack Rubinstein; Hong-Sheng Wang
Journal:  Food Chem Toxicol       Date:  2013-02-18       Impact factor: 6.023

8.  Acute postischemic treatment with estrogen receptor-alpha agonist or estrogen receptor-beta agonist improves myocardial recovery.

Authors:  Nicholas D Vornehm; Meijing Wang; Aaron Abarbanell; Jeremy Herrmann; Brent Weil; Jiangjing Tan; Yue Wang; Megan Kelly; Daniel R Meldrum
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

9.  Inactivation of Smad5 in endothelial cells and smooth muscle cells demonstrates that Smad5 is required for cardiac homeostasis.

Authors:  Lieve Umans; Luk Cox; Marc Tjwa; Virginie Bito; Liesbeth Vermeire; Kjell Laperre; Karin Sipido; Lieve Moons; Danny Huylebroeck; An Zwijsen
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

10.  Sex differences in the modulation of K+ currents in diabetic rat cardiac myocytes.

Authors:  Yakhin Shimoni; Xiu-Fang Liu
Journal:  J Physiol       Date:  2003-05-30       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.